PureTech Takes On Roche With Improved IPF Drug

Modified Version Of Esbriet Seems Safer

 
• By Ayisha Sharma
Squiggly lines from start to finish line, a straight line from start to finish underneath. Streamlined concept.
PureTech Hopes To Piggyback Off Esbriet Data For A Smoother Filing • Source: Alamy

More from Clinical Trials

More from R&D